134P Safety and efficacy of eribulin and trastuzumab in anti-HER2 therapy pretreated patients with HER2-positive metastatic breast cancer: A Japanese multicenter phase 2 study (SBP-04 study). (20th December 2016)

Record Type:: Journal Article
Title:: 134P Safety and efficacy of eribulin and trastuzumab in anti-HER2 therapy pretreated patients with HER2-positive metastatic breast cancer: A Japanese multicenter phase 2 study (SBP-04 study). (20th December 2016)
Main Title:: 134P Safety and efficacy of eribulin and trastuzumab in anti-HER2 therapy pretreated patients with HER2-positive metastatic breast cancer: A Japanese multicenter phase 2 study (SBP-04 study)
Authors:: Shien, T.
Ikeda, M.
Ohtani, S.
Hara, F.
Takahashi, M.
Tuji, H.
Yoshitomi, S.
Matsuoka, K.
Ogasawara, Y.
Taira, N.
Doihara, H.
Ohsumi, S.
Abstract:
Is Part Of:: Annals of oncology. Volume 27(2016:Sep.)Supplement 9
Journal:: Annals of oncology
Issue:: Volume 27(2016:Sep.)Supplement 9
Issue Display:: Volume 27, Issue 9 (2016)
Year:: 2016
Volume:: 27
Issue:: 9
Issue Sort Value:: 2016-0027-0009-0000
Page Start:
Page End:
Publication Date:: 2016-12-20
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdw577.017 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12575.xml